Found: 14
Select item for more details and to access through your institution.
Evaluation of Modified Crab Pots to Increase Catch of Pacific Cod and Decrease Bycatch of Pacific Halibut.
- Published in:
- North American Journal of Fisheries Management, 1997, v. 17, n. 4, p. 910, doi. 10.1577/1548-8675(1997)017<0910:EOMCPT>2.3.CO;2
- By:
- Publication type:
- Article
Comparison of a Remotely Operated Vehicle and a Submersible for Estimating Abundance of Demersal Shelf Rockfishes in the Eastern Gulf of Alaska<sup>1</sup>.
- Published in:
- North American Journal of Fisheries Management, 1994, v. 14, n. 1, p. 196, doi. 10.1577/1548-8675(1994)014<0196:COAROV>2.3.CO;2
- By:
- Publication type:
- Article
Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: data from 10 phase I trials.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 52, doi. 10.1111/bcp.13404
- By:
- Publication type:
- Article
ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S394, doi. 10.1016/S2152-2650(21)01893-0
- By:
- Publication type:
- Article
Poster:ABCL-360 Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S243, doi. 10.1016/S2152-2650(21)01526-3
- By:
- Publication type:
- Article
Oral Abstract: ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01279-9
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 6, p. 717, doi. 10.1007/s00228-017-2217-3
- By:
- Publication type:
- Article
Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL‐6 levels following administration of the T‐cell bispecific engager glofitamab.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 3, p. 396, doi. 10.1002/psp4.13091
- By:
- Publication type:
- Article
Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 6
- By:
- Publication type:
- Article
Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 4, p. 255, doi. 10.1007/s40262-013-0035-z
- By:
- Publication type:
- Article
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A test of the detection range of acoustic transmitters and receivers deployed in deep waters of Southeast Alaska, USA.
- Published in:
- Animal Biotelemetry, 2017, v. 5, p. 1, doi. 10.1186/s40317-017-0142-y
- By:
- Publication type:
- Article
Population Pharmacokinetic and Exposure‐Response Analysis of Selumetinib and Its N‐desmethyl Metabolite in Patients With Non‐Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 1, p. 112, doi. 10.1002/jcph.1295
- By:
- Publication type:
- Article